Veteran PTSD & CBD Research Study
Researchers at the VA Health Administration San Diego are conducting a research study to evaluate the effects of cannabidiol (CBD) for improving PTSD therapy outcomes among veterans. Help further research and join our study today!
Veteran PTSD & CBD Research Study
Researchers at the VA Health Administration San Diego are conducting a research study to evaluate the effects of cannabidiol (CBD) for improving PTSD therapy outcomes among veterans. Help further research and join our study today!
Living Within 50 Miles of San Diego, CA
Compensation Provided
US Veteran 18 Years or Older
Fast Facts
Experiencing Symptoms of PTSD
Study Background
Cannabidiol (CBD) is a chemical compound found in the cannabis plant. Unlike tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it doesn't produce a "high" effect when consumed.
Studies show that CBD may be able to reduce anxiety and improve the results of psychotherapy in people with anxiety disorders. This study aims to evaluate whether CBD may increase the speed and effectiveness of prolonged exposure therapy (PE), an evidence-based form of talk therapy, in veterans with post-traumatic stress disorder (PTSD).
Your participation in this study will help researchers create better treatments for individuals living with PTSD in the future. Help further clinical research and join our paid study today!
Studies show that CBD may be able to reduce anxiety and improve the results of psychotherapy in people with anxiety disorders. This study aims to evaluate whether CBD may increase the speed and effectiveness of prolonged exposure therapy (PE), an evidence-based form of talk therapy, in veterans with post-traumatic stress disorder (PTSD).
Your participation in this study will help researchers create better treatments for individuals living with PTSD in the future. Help further clinical research and join our paid study today!
Study Background Cannabidiol (CBD) is a chemical compound found in the cannabis plant. Unlike tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it doesn't produce a "high" effect when consumed. Studies show that CBD may be able to reduce anxiety and improve the results of psychotherapy in people with anxiety disorders. This study aims to evaluate whether CBD may increase the speed and effectiveness of prolonged exposure therapy (PE), an evidence-based form of talk therapy, in veterans with post-traumatic stress disorder (PTSD). Your participation in this study will help researchers create better treatments for individuals living with PTSD in the future. Help further clinical research and join our paid study today! |
Additional Information
The purpose of this study is to test the effectiveness of CBD versus a placebo for improving therapy outcomes in veterans with PTSD.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
Inclusion Criteria:
- 18+ years old
- United States veteran
- Live within 50 miles of San Diego, California
- Meet the diagnostic criteria for PTSD
- Not use cannabis 30 days before or during treatment
- Cannot be prescribed or be taking benzodiazepines
- No alcohol or any other substance use disorder treatment within the last year
If you decide to participate in this study, you will be asked to attend a 3-hour virtual assessment to determine your candidacy. Then, you will have an hour-long "meet and greet" virtual session with a study therapist and a 1-hour virtual physician appointment. You will also be asked to come to the study site to complete blood and urine lab work.
Once your eligibility has been confirmed, you will be randomly assigned into a CBD or placebo group. All participants will be scheduled for 12 90-minute virtual Prolonged Therapy sessions within 16 weeks of taking the study medication (CBD or placebo).
Weekly medication phone calls will also be scheduled to manage the study drug. Following 16 weeks of treatment, you will be scheduled for three post-treatment assessments (1 hour each, virtual) immediately after treatment, after one month, and after three months.
Once your eligibility has been confirmed, you will be randomly assigned into a CBD or placebo group. All participants will be scheduled for 12 90-minute virtual Prolonged Therapy sessions within 16 weeks of taking the study medication (CBD or placebo).
Weekly medication phone calls will also be scheduled to manage the study drug. Following 16 weeks of treatment, you will be scheduled for three post-treatment assessments (1 hour each, virtual) immediately after treatment, after one month, and after three months.
Participants will be compensated up to $75 for their time.
There is no cost for you to participate in this study.